THE MCMANUS GROUP for EMD SERONO, INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 20, 2016 | $50,000 | Replaced |
| 1st Quarter - Amendment (this page) | Jun 30, 2016 | $50,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax issues affecting pharmaceutical products, particularly new expenditures for fertility products
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| CHASE M THOMAS | — |
| BARRETT THORNHILL | — |
Health Issues HCR
General pharmaceutical coverage and reimbursement issues, health exchange policy; issues and activities affecting neurodegenerative and fertility products
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Medicare/Medicaid MMM
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products.Advocacy regarding proposed Part B demo (81 FR 13229).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.